Cargando…
Potential Diagnostic and Prognostic Value of Lymphocytic Mitochondrial DNA Deletion in Relation to Folic Acid Status in HCV-Related Hepatocellular Carcinoma
OBJECTIVE: We assessed the possibility of using mitochondrial (mt) DNA deletion as a molecular biomarker for disease progression in HCV-related hepatocellular carcinoma (HCC) and to identify its association with folic acid status. METHODS: Serum folic acid and lymphocytic mtDNA deletions were assess...
Autores principales: | Zekri, Abdel Rahman N, Salama, Hosny, Medhat, Eman, Hamdy, Sherif, Hassan, Zeinab K, Bakr, Yasser Mabrouk, Youssef, Amira Salah El - Din, Saleh, Doaa, Saeed, Ramy, Omran, Dalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720650/ https://www.ncbi.nlm.nih.gov/pubmed/28952275 http://dx.doi.org/10.22034/APJCP.2017.18.9.2451 |
Ejemplares similares
-
Consensus siRNA for inhibition of HCV genotype-4 replication
por: Zekri, Abdel Rahman N, et al.
Publicado: (2009) -
Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease
por: Salama, Hosny, et al.
Publicado: (2014) -
Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2016) -
Assessment of health-related quality of life in patients receiving stem cell therapy for end-stage liver disease: an Egyptian study
por: Salama, Hosny, et al.
Publicado: (2012) -
MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2018)